Surface epithelial-stromal tumor: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "MARIA MARIA")
No edit summary
Line 1: Line 1:
MARIA MARIA
__NOTOC__
{{SI}}                                                                 
{{CMG}} {{AE}} {{MV}}
{{SK}} Synonym 1; Synonym 2; Synonym 3
==Overview==
 
 
==Historical Perspective==
*Surface epithelial-stromal tumor was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
*In [year], [gene] mutations were first identified in the pathogenesis of surface epithelial-stromal tumor.
*In [year], the first [discovery] was developed by [scientist] to treat/diagnose surface epithelial-stromal tumor.
==Classification==
*Surface epithelial-stromal tumor may be classified according to [classification method] into [number] subtypes/groups:
:*[group1]
:*[group2]
:*[group3]
*Other variants of surface epithelial-stromal tumor include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
==Pathophysiology==
*The pathogenesis of surface epithelial-stromal tumor is characterized by [feature1], [feature2], and [feature3].
*The [gene name] gene/Mutation in [gene name] has been associated with the development of surface epithelial-stromal tumor, involving the [molecular pathway] pathway.
*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of surface epithelial-stromal tumor.
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of surface epithelial-stromal tumor.
==Causes==
* Surface epithelial-stromal tumor may be caused by either [cause1], [cause2], or [cause3].
* Surface epithelial-stromal tumor is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
* There are no established causes for surface epithelial-stromal tumor.
==Differentiating surface epithelial-stromal tumor from other Diseases==
*Surface epithelial-stromal tumor must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
:*[Differential dx1]
:*[Differential dx2]
:*[Differential dx3]
==Epidemiology and Demographics==
* The prevalence of surface epithelial-stromal tumor is approximately [number or range] per 100,000 individuals worldwide.
* In [year], the incidence of surface epithelial-stromal tumor was estimated to be [number or range] cases per 100,000 individuals in [location].
===Age===
*Patients of all age groups may develop surface epithelial-stromal tumor.
*Surface epithelial-stromal tumor is more commonly observed among patients aged [age range] years old.
*Surface epithelial-stromal tumor is more commonly observed among [elderly patients/young patients/children].
===Gender===
*Surface epithelial-stromal tumor affects men and women equally.
*[Gender 1] are more commonly affected with surface epithelial-stromal tumor than [gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
===Race===
*There is no racial predilection for surface epithelial-stromal tumor.
*Surface epithelial-stromal tumor usually affects individuals of the [race 1] race.
*[Race 2] individuals are less likely to develop surface epithelial-stromal tumor.
==Risk Factors==
*Common risk factors in the development of surface epithelial-stromal tumor are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
== Natural History, Complications and Prognosis==
*The majority of patients with surface epithelial-stromal tumor remain asymptomatic for [duration/years].
*Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
*If left untreated, [#%] of patients with surface epithelial-stromal tumor may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Common complications of surface epithelial-stromal tumor include [complication 1], [complication 2], and [complication 3].
*Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with surface epithelial-stromal tumor is approximately [#%].
== Diagnosis ==
===Diagnostic Criteria===
*The diagnosis of surface epithelial-stromal tumor is made when at least [number] of the following [number] diagnostic criteria are met:
:*[criterion 1]
:*[criterion 2]
:*[criterion 3]
:*[criterion 4]
=== Symptoms ===
*Surface epithelial-stromal tumor is usually asymptomatic.
*Symptoms of surface epithelial-stromal tumor may include the following:
:*[symptom 1]
:*[symptom 2]
:*[symptom 3]
:*[symptom 4]
:*[symptom 5]
:*[symptom 6]
=== Physical Examination ===
*Patients with surface epithelial-stromal tumor usually appear [general appearance].
*Physical examination may be remarkable for:
:*[finding 1]
:*[finding 2]
:*[finding 3]
:*[finding 4]
:*[finding 5]
:*[finding 6]
=== Laboratory Findings ===
*There are no specific laboratory findings associated with surface epithelial-stromal tumor.
 
*A  [positive/negative] [test name] is diagnostic of surface epithelial-stromal tumor.
*An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of surface epithelial-stromal tumor.
*Other laboratory findings consistent with the diagnosis of surface epithelial-stromal tumor include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
===Imaging Findings===
*There are no [imaging study] findings associated with surface epithelial-stromal tumor.
*[Imaging study 1] is the imaging modality of choice for surface epithelial-stromal tumor.
*On [imaging study 1], surface epithelial-stromal tumor is characterized by [finding 1], [finding 2], and [finding 3].
*[Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
=== Other Diagnostic Studies ===
*Surface epithelial-stromal tumor may also be diagnosed using [diagnostic study name].
*Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
== Treatment ==
=== Medical Therapy ===
*There is no treatment for surface epithelial-stromal tumor; the mainstay of therapy is supportive care.
*The mainstay of therapy for surface epithelial-stromal tumor is [medical therapy 1] and [medical therapy 2].
*[Medical therapy 1] acts by [mechanism of action1].
*Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
=== Surgery ===
*Surgery is the mainstay of therapy for surface epithelial-stromal tumor.
*[Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of surface epithelial-stromal tumor.
*[Surgical procedure] can only be performed for patients with [disease stage] surface epithelial-stromal tumor.
=== Prevention ===
*There are no primary preventive measures available for surface epithelial-stromal tumor.
*Effective measures for the primary prevention of surface epithelial-stromal tumor include [measure1], [measure2], and [measure3].
 
*Once diagnosed and successfully treated, patients with surface epithelial-stromal tumor are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
==References==
{{Reflist|2}}
[[Category:Pick One of 28 Approved]]

Revision as of 13:50, 18 April 2016

WikiDoc Resources for Surface epithelial-stromal tumor

Articles

Most recent articles on Surface epithelial-stromal tumor

Most cited articles on Surface epithelial-stromal tumor

Review articles on Surface epithelial-stromal tumor

Articles on Surface epithelial-stromal tumor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Surface epithelial-stromal tumor

Images of Surface epithelial-stromal tumor

Photos of Surface epithelial-stromal tumor

Podcasts & MP3s on Surface epithelial-stromal tumor

Videos on Surface epithelial-stromal tumor

Evidence Based Medicine

Cochrane Collaboration on Surface epithelial-stromal tumor

Bandolier on Surface epithelial-stromal tumor

TRIP on Surface epithelial-stromal tumor

Clinical Trials

Ongoing Trials on Surface epithelial-stromal tumor at Clinical Trials.gov

Trial results on Surface epithelial-stromal tumor

Clinical Trials on Surface epithelial-stromal tumor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Surface epithelial-stromal tumor

NICE Guidance on Surface epithelial-stromal tumor

NHS PRODIGY Guidance

FDA on Surface epithelial-stromal tumor

CDC on Surface epithelial-stromal tumor

Books

Books on Surface epithelial-stromal tumor

News

Surface epithelial-stromal tumor in the news

Be alerted to news on Surface epithelial-stromal tumor

News trends on Surface epithelial-stromal tumor

Commentary

Blogs on Surface epithelial-stromal tumor

Definitions

Definitions of Surface epithelial-stromal tumor

Patient Resources / Community

Patient resources on Surface epithelial-stromal tumor

Discussion groups on Surface epithelial-stromal tumor

Patient Handouts on Surface epithelial-stromal tumor

Directions to Hospitals Treating Surface epithelial-stromal tumor

Risk calculators and risk factors for Surface epithelial-stromal tumor

Healthcare Provider Resources

Symptoms of Surface epithelial-stromal tumor

Causes & Risk Factors for Surface epithelial-stromal tumor

Diagnostic studies for Surface epithelial-stromal tumor

Treatment of Surface epithelial-stromal tumor

Continuing Medical Education (CME)

CME Programs on Surface epithelial-stromal tumor

International

Surface epithelial-stromal tumor en Espanol

Surface epithelial-stromal tumor en Francais

Business

Surface epithelial-stromal tumor in the Marketplace

Patents on Surface epithelial-stromal tumor

Experimental / Informatics

List of terms related to Surface epithelial-stromal tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Overview

Historical Perspective

  • Surface epithelial-stromal tumor was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
  • In [year], [gene] mutations were first identified in the pathogenesis of surface epithelial-stromal tumor.
  • In [year], the first [discovery] was developed by [scientist] to treat/diagnose surface epithelial-stromal tumor.

Classification

  • Surface epithelial-stromal tumor may be classified according to [classification method] into [number] subtypes/groups:
  • [group1]
  • [group2]
  • [group3]
  • Other variants of surface epithelial-stromal tumor include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

  • The pathogenesis of surface epithelial-stromal tumor is characterized by [feature1], [feature2], and [feature3].
  • The [gene name] gene/Mutation in [gene name] has been associated with the development of surface epithelial-stromal tumor, involving the [molecular pathway] pathway.
  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of surface epithelial-stromal tumor.
  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of surface epithelial-stromal tumor.

Causes

  • Surface epithelial-stromal tumor may be caused by either [cause1], [cause2], or [cause3].
  • Surface epithelial-stromal tumor is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
  • There are no established causes for surface epithelial-stromal tumor.

Differentiating surface epithelial-stromal tumor from other Diseases

  • Surface epithelial-stromal tumor must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
  • [Differential dx1]
  • [Differential dx2]
  • [Differential dx3]

Epidemiology and Demographics

  • The prevalence of surface epithelial-stromal tumor is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of surface epithelial-stromal tumor was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

  • Patients of all age groups may develop surface epithelial-stromal tumor.
  • Surface epithelial-stromal tumor is more commonly observed among patients aged [age range] years old.
  • Surface epithelial-stromal tumor is more commonly observed among [elderly patients/young patients/children].

Gender

  • Surface epithelial-stromal tumor affects men and women equally.
  • [Gender 1] are more commonly affected with surface epithelial-stromal tumor than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for surface epithelial-stromal tumor.
  • Surface epithelial-stromal tumor usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop surface epithelial-stromal tumor.

Risk Factors

  • Common risk factors in the development of surface epithelial-stromal tumor are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with surface epithelial-stromal tumor remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with surface epithelial-stromal tumor may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of surface epithelial-stromal tumor include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with surface epithelial-stromal tumor is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of surface epithelial-stromal tumor is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

  • Surface epithelial-stromal tumor is usually asymptomatic.
  • Symptoms of surface epithelial-stromal tumor may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination

  • Patients with surface epithelial-stromal tumor usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with surface epithelial-stromal tumor.
  • A [positive/negative] [test name] is diagnostic of surface epithelial-stromal tumor.
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of surface epithelial-stromal tumor.
  • Other laboratory findings consistent with the diagnosis of surface epithelial-stromal tumor include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • There are no [imaging study] findings associated with surface epithelial-stromal tumor.
  • [Imaging study 1] is the imaging modality of choice for surface epithelial-stromal tumor.
  • On [imaging study 1], surface epithelial-stromal tumor is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • Surface epithelial-stromal tumor may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for surface epithelial-stromal tumor; the mainstay of therapy is supportive care.
  • The mainstay of therapy for surface epithelial-stromal tumor is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for surface epithelial-stromal tumor.
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of surface epithelial-stromal tumor.
  • [Surgical procedure] can only be performed for patients with [disease stage] surface epithelial-stromal tumor.

Prevention

  • There are no primary preventive measures available for surface epithelial-stromal tumor.
  • Effective measures for the primary prevention of surface epithelial-stromal tumor include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with surface epithelial-stromal tumor are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References